Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell A Avery

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Current Pharmaceutical Design|April 8, 2003
Giardiasis: recent progress in chemotherapy and drug developmentTomoko Minenoa, Mitchell A Avery
Drug Discovery Today|May 30, 2009
Progress in the development of peroxide-based anti-parasitic agentsK M Muraleedharan, Mitchell A Avery
Bioorganic & Medicinal Chemistry Letters|August 11, 2012
Combined receptor-based and ligand-based approach to delineate the mode of binding of guaianolide-endoperoxides to PfATP6Mohamed A Helal, Mitchell A Avery
Organic Letters|November 25, 2003
Cyanthiwigin AC and AD, two novel diterpene skeletons from the Jamaican sponge Myrmekioderma styxJiangnan Peng, Mitchell A Avery, Mark T Hamann
Journal of Molecular Graphics & Modelling|June 24, 2008
QM/QM studies for Michael reaction in coronavirus main protease (3CL Pro)Alex G Taranto, Paulo Carvalho, Mitchell A Avery
Journal of Computer-Aided Molecular Design|September 18, 2007
Toward Mycobacterium tuberculosis DXR inhibitor design: homology modeling and molecular dynamics simulationsNidhi Singh, Mitchell A Avery, Christopher R McCurdy
Proteins|October 13, 2006
Ligand-supported homology modeling of the human angiotensin II type 1 (AT(1)) receptor: insights into the molecular determinants of telmisartan bindingAkshay Patny, Prashant V Desai, Mitchell A Avery
Current Medicinal Chemistry|June 22, 2006
Homology modeling of G-protein-coupled receptors and implications in drug designAkshay Patny, Prashant V Desai, Mitchell A Avery
Current Medicinal Chemistry|January 29, 2008
The fight against drug-resistant malaria: novel plasmodial targets and antimalarial drugsSeoung-Ryoung Choi, Prasenjit Mukherjee, Mitchell A Avery
Chemistry & Biodiversity|May 13, 2017
Design, Synthesis, and Biological Evaluation of Peptidomimetic N-Substituted Cbz-4-Hyp-Hpa-Amides as Novel Inhibitors of Plasmodium falciparumValeriy A Bacherikov, Amar G Chittiboyina, Mitchell A Avery
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Current Pharmaceutical Design|April 8, 2003
Giardiasis: recent progress in chemotherapy and drug developmentTomoko Minenoa, Mitchell A Avery
Drug Discovery Today|May 30, 2009
Progress in the development of peroxide-based anti-parasitic agentsK M Muraleedharan, Mitchell A Avery
Bioorganic & Medicinal Chemistry Letters|August 11, 2012
Combined receptor-based and ligand-based approach to delineate the mode of binding of guaianolide-endoperoxides to PfATP6Mohamed A Helal, Mitchell A Avery
Organic Letters|November 25, 2003
Cyanthiwigin AC and AD, two novel diterpene skeletons from the Jamaican sponge Myrmekioderma styxJiangnan Peng, Mitchell A Avery, Mark T Hamann
Journal of Molecular Graphics & Modelling|June 24, 2008
QM/QM studies for Michael reaction in coronavirus main protease (3CL Pro)Alex G Taranto, Paulo Carvalho, Mitchell A Avery
Journal of Computer-Aided Molecular Design|September 18, 2007
Toward Mycobacterium tuberculosis DXR inhibitor design: homology modeling and molecular dynamics simulationsNidhi Singh, Mitchell A Avery, Christopher R McCurdy
Proteins|October 13, 2006
Ligand-supported homology modeling of the human angiotensin II type 1 (AT(1)) receptor: insights into the molecular determinants of telmisartan bindingAkshay Patny, Prashant V Desai, Mitchell A Avery
Current Medicinal Chemistry|June 22, 2006
Homology modeling of G-protein-coupled receptors and implications in drug designAkshay Patny, Prashant V Desai, Mitchell A Avery
Current Medicinal Chemistry|January 29, 2008
The fight against drug-resistant malaria: novel plasmodial targets and antimalarial drugsSeoung-Ryoung Choi, Prasenjit Mukherjee, Mitchell A Avery
Chemistry & Biodiversity|May 13, 2017
Design, Synthesis, and Biological Evaluation of Peptidomimetic N-Substituted Cbz-4-Hyp-Hpa-Amides as Novel Inhibitors of Plasmodium falciparumValeriy A Bacherikov, Amar G Chittiboyina, Mitchell A Avery
Pageof 10